Second European Stroke Prevention Study. ESPS-2 Working Group.
The computerized design, aims, organization, and structure of the European Stroke Prevention Study 2 (ESPS-2) are presented. This clinical trial will investigate the effect of single and combination regimens of low-dose acetylsalicylic acid (50 mg daily) and dipyridamole (400 mg daily) versus placebo in secondary prevention of stroke and death.
D001241:Aspirin / Q000008:administration & dosage*; D002545:Brain Ischemia / Q000401:mortality / Q000517:prevention & control*; D003198:Computer Simulation; D004176:Dipyridamole / Q000008:administration & dosage*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D001330:Electronic Data Processing; D005500:Follow-Up Studies; D006801:Humans; D008954:Models, Biological; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D013813:Therapy, Computer-Assisted
D004176:Dipyridamole; D001241:Aspirin